Clinical Trial Update: Buprenorphine vs Buprenorphine/Naloxone on the Effects of Maternal Symptomatology [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing buprenorphine alone versus buprenorphine with naloxone for maternal symptomatology in opioid-use disorder was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Stony Brook University | Conditions: Opioid-use Disorder | Phase 4 | Status: WITHDRAWN